Some of the services RMI can offer:
-
Developing pharmacokinetic discovery and early development strategies to minimize project cycle times with drug candidates less likely to fail in later development
-
Devise strategies for overcoming or exploiting the blood brain barrier
-
Guide strategies that identify potentially clinically relevant drug-drug interactions so they can be either designed out or mitigated
-
Devise early/exploratory clinical development plans that speed to key decisions such as microdosing, low pharmacologically active doses (PADS) and the effective use of biomarkers
-
Use pharmacokinetics and pharmacodynamics to design optimum dosage regimens
-
Prepare and/or review drug metabolism and pharmacokinetic aspects of key documentation including due diligences
-
Training in pharmacokinetics and drug metabolism tailored to meet the specific needs of the pharmaceutical and biotechnology industry